Substituted azole compound and antidiabetes agent

To provide a novel substituted azole compound having a GPR119-activating activity and useful particularly for the prevention and/or treatment of diabetes and obesity. Provided are: a novel substituted azole compound represented by formula (I) (wherein each substituent is as defined in detail in the...

Full description

Saved in:
Bibliographic Details
Main Authors SHINTANI, YUSUKE, MONMA, SOUICHI, SHIGETA, YUKIHIRO, KAMIYAMA, TOSHIHIKO, NIWA, MASATOSHI, SHIMAZAWA, YOSHINOBU, OKADA, KAZUAKI, ISHIYAMA, SEISHI
Format Patent
LanguageChinese
English
Published 16.07.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To provide a novel substituted azole compound having a GPR119-activating activity and useful particularly for the prevention and/or treatment of diabetes and obesity. Provided are: a novel substituted azole compound represented by formula (I) (wherein each substituent is as defined in detail in the description; the ring A represents an aromatic ring which may be substituted by a substituent as defined in the description; the ring B represents a ring selected from rings represented by formula (II); R1 represents a hydrogen atom, an alkyl group or the like; R2 represents an alkyl group or the like; the ring C represents a benzene ring, a 5- to 6-membered aromatic heterocyclic ring or the like; and R3 and R4 independently represent an alkyl group which may be substituted or the like), a tautomer or pharmaceutically acceptable salt of the compound, or a solvate of the compound or the tautomer or pharmaceutically acceptable salt.
Bibliography:Application Number: TW20150115166